Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism - Egan, KM; Wang, M; Lucitt, MB (Circulation, 2005)
et al.